{"id":1368,"date":"2026-03-02T10:06:06","date_gmt":"2026-03-02T10:06:06","guid":{"rendered":"https:\/\/sites.abo.fi\/madness\/?post_type=events&#038;p=1368"},"modified":"2026-03-02T10:06:06","modified_gmt":"2026-03-02T10:06:06","slug":"spark-webinar-the-business-of-biotech-from-spin-offs-to-thriving-ventures","status":"publish","type":"events","link":"https:\/\/sites.abo.fi\/madness\/events\/spark-webinar-the-business-of-biotech-from-spin-offs-to-thriving-ventures\/","title":{"rendered":"SPARK Webinar: The Business of Biotech: From Spin-offs to Thriving Ventures"},"content":{"rendered":"\n<p><strong>SPARK Webinar<\/strong><\/p>\n\n\n\n<p>19<sup>th<\/sup> March at 16:30-17:30<br>Online event<br>in Teams<br><a href=\"https:\/\/biocityturku.fi\/wp-content\/uploads\/Flyer_SPARK-BIH-National-GCT_2026_Webinar_Peggy-Sotiropoulou_.pdf\">Flyer<\/a><\/p>\n\n\n\n<p><strong>Peggy Sotiropoulou<\/strong>, Chief Scientific Officer at T-Knife Therapeutics<br><em>The Business of Biotech: From Spin-offs to Thriving Ventures<\/em><\/p>\n\n\n\n<p>Registration to the webinar is required in advance in order to receive MS Teams meeting link: <a href=\"https:\/\/forms.office.com\/pages\/responsepage.aspx?id=ORnprz6SLEO8ZsvD7BjQLLal1MWqsCZCmMJWEnMFUXlUQko5NFQ2TEtJSlE1R05FMDk1QjlHN05ERi4u&amp;route=shorturl\" target=\"_blank\" rel=\"noreferrer noopener\">19.3. The Business of Biotech: From Spin-offs to Thriving Ventures, Peggy Sotiropoulou<\/a><\/p>\n\n\n\n<p>The event is hosted by SPARK-BIH at the Berlin Institute of Health at Charit\u00e9, Berlin, Germany. SPARK is an initiative created at Stanford University to overcome challenges associated with translation of academic discoveries<\/p>\n","protected":false},"excerpt":{"rendered":"<p>SPARK Webinar 19th March at 16:30-17:30Online eventin TeamsFlyer Peggy Sotiropoulou, Chief Scientific Officer at T-Knife TherapeuticsThe Business of Biotech: From Spin-offs to Thriving Ventures Registration to the webinar is required in advance in order to receive MS Teams meeting link: 19.3. The Business of Biotech: From Spin-offs to Thriving Ventures, Peggy Sotiropoulou The event is&#8230;<\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":true,"inline_featured_image":false,"_kad_blocks_custom_css":"","_kad_blocks_head_custom_js":"","_kad_blocks_body_custom_js":"","_kad_blocks_footer_custom_js":"","_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":""},"categories":[],"tags":[],"class_list":["post-1368","events","type-events","status-publish","hentry"],"acf":[],"lang":"en","translations":{"en":1368},"taxonomy_info":[],"featured_image_src_large":false,"author_info":[],"comment_info":"","pll_sync_post":[],"_links":{"self":[{"href":"https:\/\/sites.abo.fi\/madness\/wp-json\/wp\/v2\/events\/1368","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sites.abo.fi\/madness\/wp-json\/wp\/v2\/events"}],"about":[{"href":"https:\/\/sites.abo.fi\/madness\/wp-json\/wp\/v2\/types\/events"}],"wp:attachment":[{"href":"https:\/\/sites.abo.fi\/madness\/wp-json\/wp\/v2\/media?parent=1368"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sites.abo.fi\/madness\/wp-json\/wp\/v2\/categories?post=1368"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sites.abo.fi\/madness\/wp-json\/wp\/v2\/tags?post=1368"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}